Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
about
Translating extracellular microRNA into clinical biomarkers for drug-induced toxicity: from high-throughput profiling to validationmicroRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentMicroRNAs in Drug-induced Liver InjuryMicroRNAs and benign biliary tract diseasesNanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis.Mitofusin 2 protects hepatocyte mitochondrial function from damage induced by GCDCA.Exosomal and Non-Exosomal Transport of Extra-Cellular microRNAs in Follicular Fluid: Implications for Bovine Oocyte Developmental Competence.Translational biomarkers of acetaminophen-induced acute liver injuryMechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different gradesIncubation of whole blood at room temperature does not alter the plasma concentrations of microRNA-16 and -223.Beyond miR-122: Identification of MicroRNA Alterations in Blood During a Time Course of Hepatobiliary Injury and Biliary Hyperplasia in RatsMicroRNA profiles in a monkey testicular injury model induced by testicular hyperthermia.Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury.Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease.Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease.Development and regulatory application of microRNA biomarkers.Expression profiles and circulation dynamics of rat mesenteric lymph microRNAsMicroRNA Biomarkers of Toxicity in Biological Matrices.MicroRNAs in injury and repair.Induction of microRNA-214-5p in human and rodent liver fibrosis.Time-course changes in the expression levels of miR-122, -155, and -21 as markers of liver cell damage, inflammation, and regeneration in acetaminophen-induced liver injury in rats.Ratio of microRNA-122/155 in isoniazid-induced acute liver injury in mice.Identification of microRNA biomarker candidates in urine and plasma from rats with kidney or liver damageMicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicityInhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2-/- mice.Current trends in in silico, in vitro toxicology, and safety biomarkers in early drug development.Comprehensive Analysis of Circulating microRNA Specific to the Liver, Heart, and Skeletal Muscle of Cynomolgus Monkeys.MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury.Circulating liver-specific microRNAs in cynomolgus monkeys.miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.
P2860
Q26778915-00437EC3-890D-4798-8AF6-3462949993F5Q26778918-9A9B59CD-524A-4D5D-ACE1-A8A99F6DCC94Q26781801-CCAEFB32-381A-4020-A05F-1D4D20751CE6Q26865762-EE05632D-4FE7-4C01-B1B6-4419D3EA40C3Q30697447-494F24B2-60E9-4455-89C0-4177151EB0B4Q34766553-853EF43B-3784-4559-96ED-ECCF3101B523Q35040950-04643B3B-E47A-4069-9160-B9440FEFF11DQ36001451-A8B6211F-C2C2-43BD-8ADB-88C69E7B1C97Q36764809-5BED02AD-3FF0-47EC-8383-426461297ABFQ37193081-FAC16A06-A1FE-4089-BEC1-6FA7A5F8D451Q37228567-DD1339C4-DF53-4739-87A3-D084EDC56E01Q37412904-326DDBEF-E5F0-4EA5-B9FD-E45842FB4922Q38095111-AC2B602B-444E-487F-A2B5-1D8A4D4598D4Q38202220-CBE3EBA3-DE32-4B3A-B2BC-863423FC3FB4Q38246145-6DA59C23-AF49-42FF-8C20-0C9A950F40FDQ38616581-B1145DCD-AFF8-4650-80B8-07CD6DF2A05AQ38713846-C8706BF0-4A92-444A-B08D-61029FAFFDECQ38909827-58490B78-EB20-458A-A998-78AA81CFB6B6Q39304689-0A5FDCE8-9012-4279-A7E4-D637ABC60BD0Q39304895-AB6C330C-5B55-4DD2-911F-3A01E7260AAAQ39532121-D57E9E7A-9DFB-4B52-8BFE-A6A3E2E31D92Q41867355-AC69F32F-8ED0-4F83-AA96-66752E0D3A33Q42323176-8D0B8343-1773-4441-88A0-E511D688E289Q42364556-190119C8-640F-48C6-A7C5-C53D8FF874D1Q47389654-922143FA-69C8-40CA-8A67-CBC68BE4B65DQ47434464-6CE50790-D325-4E5C-9E8F-D1F7E633A064Q47777069-BB307360-6831-409A-B375-2675D756F6F2Q49862111-D2367CDD-9A3F-49D7-84E4-0E6AA03DA286Q50315404-C8E91910-B617-4E75-8AA3-C3CBEE678E24Q53099936-9E79171F-0AB7-4A19-B35C-F6D96BFA35A4
P2860
Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Plasma microRNA profiles in ra ...... y, cholestasis, and steatosis.
@ast
Plasma microRNA profiles in ra ...... y, cholestasis, and steatosis.
@en
Plasma microRNA profiles in ra ...... y, cholestasis, and steatosis.
@nl
type
label
Plasma microRNA profiles in ra ...... y, cholestasis, and steatosis.
@ast
Plasma microRNA profiles in ra ...... y, cholestasis, and steatosis.
@en
Plasma microRNA profiles in ra ...... y, cholestasis, and steatosis.
@nl
prefLabel
Plasma microRNA profiles in ra ...... y, cholestasis, and steatosis.
@ast
Plasma microRNA profiles in ra ...... y, cholestasis, and steatosis.
@en
Plasma microRNA profiles in ra ...... y, cholestasis, and steatosis.
@nl
P2093
P2860
P1433
P1476
Plasma microRNA profiles in ra ...... y, cholestasis, and steatosis.
@en
P2093
Koichi Tsuneyama
Miki Nakajima
Shingo Takagi
Tatsuki Fukami
Tsuyoshi Yokoi
Yu Yamaura
P2860
P304
P356
10.1371/JOURNAL.PONE.0030250
P407
P577
2012-02-17T00:00:00Z